Literature DB >> 16598975

Comparison of results of medial rectus muscle recession using augmentation, Faden procedure, and slanted recession in the treatment of high accommodative convergence/accommodation ratio esotropia.

Davoud Gharabaghi1, Leila Kazemi Zanjani.   

Abstract

BACKGROUND AND
PURPOSE: According to the literature, accommodative esotropia has an unpredictable course when nonsurgical treatment is considered, especially in cases with a high accommodative convergence/accommodation ratio (AC/A). The aim of this study was to compare the results of augmented recession, slanted recession, and recession with posterior fixation suture of the medial rectus muscles in the treatment of high AC/A esotropia. SUBJECTS AND METHODS: Twenty-eight children (4 to 14 years old) with high AC/A esotropia with a near-distance disparity greater than 10 PD were included in a prospective, randomized, blinded clinical trial. Nine children underwent recession of both medial rectus muscles and posterior fixation suture (Faden procedure), 9 children underwent augmented recession of the medial rectus muscles, and 10 children underwent slanted recession of both medial rectus muscles. The amount of esodeviation was measured before strabismus surgery and at least 6 months postoperatively.
RESULTS: In the augmented recession group, the mean near-distance disparity was reduced from 16.33 +/- 2.17 PD preoperatively to 7.55 +/- 3.87 PD postoperatively (54.21%; P = .056). In the Faden procedure group, it was reduced from 15.22 +/- 4.08 PD to 2.55 +/- 4.03 PD (80.7%; P = .056). In the slanted recession group, it was reduced from 15.50 +/- 4.30 PD to 4.10 +/- 4.80 PD (67.55%; P = .056).
CONCLUSIONS: The Faden procedure had the best outcome, but slanted recession also was successful. Because of our good results and an easy, non-invasive approach without any additional complications, we recommend slanted recession to treat high AC/A esotropia.

Entities:  

Mesh:

Year:  2006        PMID: 16598975     DOI: 10.3928/0191-3913-20060301-08

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  8 in total

Review 1.  Surgical treatment for residual or recurrent strabismus.

Authors:  Tao Wang; Li-Hua Wang
Journal:  Int J Ophthalmol       Date:  2014-12-18       Impact factor: 1.779

2.  The change of the extraocular muscle insertion after a slanted recession in rabbit eyes.

Authors:  Minwook Chang; Joong-Hoon Kim; Seung-Hyun Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-09       Impact factor: 3.117

3.  Y-splitting medial rectus muscle and recession in treatment for convergence excess esotropia.

Authors:  Li-Juan Huang; Yu-Yu Wu; Ning-Dong Li
Journal:  Int J Ophthalmol       Date:  2022-04-18       Impact factor: 1.779

4.  Long-term outcome of medial rectus recession and pulley posterior fixation in esotropia with high AC/A ratio.

Authors:  Geoffrey Wabulembo; Joseph L Demer
Journal:  Strabismus       Date:  2012-09

5.  The analysis of AC/A ratio in nonrefractive accommodative esotropia treated with bifocal glasses.

Authors:  Wook Kyum Kim; Sung Yong Kang; Soolienah Rhiu; Seung Ah Chung; Jong Bok Lee
Journal:  Korean J Ophthalmol       Date:  2012-01-14

6.  Y-Split Recession of the Medial Rectus Muscle as a Secondary and/or Unilateral Procedure in the Treatment of Esotropia with Distance/Near Disparity.

Authors:  Monika Wipf; Siegfried Priglinger; Anja Palmowski-Wolfe
Journal:  J Ophthalmol       Date:  2017-07-19       Impact factor: 1.909

7.  Outcome of Esotropia Surgery in 2 Tertiary Hospitals in Cameroon.

Authors:  Viola Andin Dohvoma; Stève Robert Ebana Mvogo; Jean Audrey Ndongo; Caroline Tsimi Mvilongo; Côme Ebana Mvogo
Journal:  Clin Ophthalmol       Date:  2020-02-13

Review 8.  Slanted versus Augmented Recession for Horizontal Strabismus.

Authors:  Zhale Rajavi; Mohadeseh Feizi; Sayed Aliasghar Nabavi; Hamideh Sabbaghi; Narges Behradfar; M S Mehdi Yaseri; Mohammad Faghihi; Saeid Abdi
Journal:  J Ophthalmic Vis Res       Date:  2019-10-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.